Laura E. Via

14.6k citations

101 papers · 8.3k indexed · 3 hit papers · h-index 46

Infectious Diseases top 0.1%
- Tuberculosis Research and Epidemiology 79
Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria 10
Epidemiology top 0.5%
- Mycobacterium research and diagnosis 43
- Pneumocystis jirovecii pneumonia detection and treatment 11
- Pneumonia and Respiratory Infections 8
Immunology top 2%
Endocrinology top 2%
Surgery
- Infectious Diseases and Tuberculosis 18
- Diagnosis and treatment of tuberculosis 9
Molecular Biology
- Cancer therapeutics and mechanisms 10

Co-authors: Clifton E. Barry C. Neal Stewart Vojo Deretić Véronique Dartois Dominique J. Wiener Dusanka Deretic JoAnne L. Flynn Sang-Nae Cho
Cited by: Infectious Diseases Molecular Medicine Epidemiology
Journals: Antimicrobial Agents and Chemotherapy (10 papers)Journal of Clinical Microbiology (5 papers)PLoS ONE (5 papers)
Partner nations: United States South Africa South Korea

In The Last Decade

Laura E. Via

100 papers receiving 8.1k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Laura E. Via

Since Specialization

Citations

This map shows the geographic impact of Laura E. Via's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura E. Via with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura E. Via more than expected).

Fields of papers citing papers by Laura E. Via

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura E. Via. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura E. Via. The network helps show where Laura E. Via may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Laura E. Via, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Laura E. Via Line = papers co-authored together Laura E. Via links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The Kinetics of Bedaquiline Diffusion in Tuberculous Cavities Open a Window for the Emergence of Resistance The Journal of Infectious Diseases ·Annamarie E. Bustion,M S Quesada,Firat Kaya,焦成根,Jansy P. Sarathy,Landry Blanc,Marjorie Z. Imperial,Martin Gengenbacher,Min Xie,Matthew Zimmerman,Gregory T. Robertson,Dominique J. Wiener,Laura E. Via,Clifton E. Barry,Radojka M. Savić,Véronique Dartois	2025	0
2	IQGAP1 domesticates macrophages to favor mycobacteria survival via modulating NF-κB signal and augmenting VEGF secretion International Immunopharmacology ·Xin Wen,Dan Li,Hankun Wang,Ding Zhang,匠岡田,Ziwei Zhou,Wei-Feng Huang,Xuan Xia,Xiaohong Hu,Wei Liu,Jacqueline Gonzales,Laura E. Via,Lu Zhang,Decheng Wang	2024	1
3	Role of DNA Double-Strand Break Formation in Gyrase Inhibitor-Mediated Killing of Nonreplicating Persistent Mycobacterium tuberculosis in Caseum ACS Infectious Diseases ·Hou-Chuan Lai,Stp. M.P. Novita Erma Kristanti,Dominique J. Wiener,Laura E. Via,Jansy P. Sarathy	2024	1
4	Normalizing granuloma vasculature and matrix improves drug delivery and reduces bacterial burden in tuberculosis-infected rabbits Proceedings of the National Academy of Sciences ·Meenal Datta,Laura E. Via,Véronique Dartois,Dominique J. Wiener,Matthew Zimmerman,Firat Kaya,Kimura Yoshitaka,Usman Muhammad,Umar Nabi Tak,Yuankun Wu,Manfred Wilhelmy Von Wolff,Walid S. Kamoun,Adriano Wagner,Ashwin S. Kumar,Sonu Subudhi,Lei Xu,Clifton E. Barry,Rakesh K. Jain	2024	10
5	Sputum lipoarabinomannan (LAM) as a biomarker to determine sputum mycobacterial load: exploratory and model-based analyses of integrated data from four cohorts BMC Infectious Diseases ·Tripti Bhattacharyya,Miwa AZUMA,Belinda Kriel,Laura E. Via,Yin Cai,Stanwood Richardson Duval,Debra Hanna,David Hermann,André G. Loxton,Gerhard Walzl,Andreas H. Diacon,Klaus Romero,Guobing Yu,Yongge Liu,Alexander Berg	2022	11
6	Visualizing the dynamics of tuberculosis pathology using molecular imaging Journal of Clinical Investigation ·Alvaro A. Ordoñez,Elizabeth W. Tucker,Carolyn J. Anderson,Claire L. Carter,Shashank Ganatra,Deepak Kaushal,Igor Kramnik,Philana Ling Lin,Cressida A. Madigan,Susana Méndez,Jianghong Rao,Rada Savic,David M. Tobin,Gerhard Walzl,Robert J. Wilkinson,J J Polk,Laura E. Via,Sanjay K. Jain	2021	17
7	Plasticity of the Mycobacterium tuberculosis respiratory chain and its impact on tuberculosis drug development Nature Communications ·将史高見,Kathryn O’Brien,Divya Tiwari,Curtis A. Engelhart,Shaun B. Walters,邓阿丽,Hee‐Jeong Yang,原田やよい,Dominique J. Wiener,Emmanuel K. Dayao,Matthew Zimmerman,Brendan Prideaux,Prashant Desai,Thierry Masquelin,Laura E. Via,Véronique Dartois,Helena I. Boshoff,Clifton E. Barry,Sabine Ehrt,Dirk Schnappinger	2019	86
8	Tuberculosis drugs’ distribution and emergence of resistance in patient’s lung lesions: A mechanistic model and tool for regimen and dose optimization PLoS Medicine ·Natasha Strydom,Sneha Gupta,Melissa Kuznik,Laura E. Via,Hyeeun Bang,Myungsun Lee,Seok‐Yong Eum,Tae Sun Shim,Clifton E. Barry,Matthew Zimmerman,Véronique Dartois,Radojka M. Savić	2019	134
9	Discovery and Structure–Activity-Relationship Study of N-Alkyl-5-hydroxypyrimidinone Carboxamides as Novel Antitubercular Agents Targeting Decaprenylphosphoryl-β-d-ribose 2′-Oxidase Journal of Medicinal Chemistry ·Sangmi Oh,Yumi Park,Curtis A. Engelhart,Joshua B. Wallach,Dirk Schnappinger,Kriti Arora,Yu-Xiong Yan,R. Karthikeyani,Hongwu Wang,Nicholas Murgolo,David B. Olsen,Michael Goodwin,S D Ding,Dominique J. Wiener,Laura E. Via,Helena I. Boshoff,Clifton E. Barry	2018	29
10	Extreme Drug Tolerance of Mycobacterium tuberculosis in Caseum Antimicrobial Agents and Chemotherapy ·Jansy P. Sarathy,Laura E. Via,Dominique J. Wiener,Landry Blanc,Helena I. Boshoff,Eliseo A. Eugenín,Clifton E. Barry,Véronique Dartois	2017	159
11	An <em>In Vitro</em> Caseum Binding Assay that Predicts Drug Penetration in Tuberculosis Lesions Journal of Visualized Experiments ·Jansy P. Sarathy,Ilori,Dominique J. Wiener,Jacqueline Gonzales,Laura E. Via,Véronique Dartois	2017	19
12	Bacterial Loads Measured by the Xpert MTB/RIF Assay as Markers of Culture Conversion and Bacteriological Cure in Pulmonary TB PLoS ONE ·Shubhada Shenai,Katharina Ronacher,Ummi Uswatun Hasanah,Kim Stanley,Magdalena Kriel,Jill Winter,Thomas Peppard,Mia Coll Mariné,Jing Wang,Lori E. Dodd,Laura E. Via,Clifton E. Barry,Gerhard Walzl,David Alland	2016	29
13	Inflammatory signaling in human tuberculosis granulomas is spatially organized Nature Medicine ·Mohlopheni J. Marakalala,Ravikiran M. Raju,Kirti Sharma,Yanjia J. Zhang,Eliseo A. Eugenín,Brendan Prideaux,Isaac Daudelin,Pei‐Yu Chen,Matthew G. Booty,Jin Hee Kim,Seok Yong Eum,Laura E. Via,Samuel M. Behar,Clifton E. Barry,Matthias Mann,Véronique Dartois,Eric J. Rubin	2016	221
14	Within patient microevolution of Mycobacterium tuberculosis correlates with heterogeneous responses to treatment Scientific Reports ·Qingyun Liu,Laura E. Via,Tāo Luò,Lili Liang,Xin Liu,Saulius Pilkaviius,Damian Pazdziernik,Wei Wang,Xianglin Ruan,Xing Yuan,Guolong Zhang,Clifton E. Barry,Qian Gao	2015	72
15	Nuclear imaging: A powerful novel approach for tuberculosis Nuclear Medicine and Biology ·Daniel Johnson,Laura E. Via,Peter Kim,Dominick J. Laddy,Chuen‐Yen Lau,Edward A. Weinstein,Sanjay K. Jain	2014	21
16	Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study The Lancet ·Tracy Dalton,Peter Cegielski,Somsak Akksilp,Luis Asencios,Janice Caoili,Sang-Nae Cho,В В Ерохин,Julia Ershova,Ma Tarcela Gler,Boris Y. Kazennyy,Hee Jin Kim,Kai Kliiman,Ekaterina V. Kurbatova,Charlotte Kvasnovsky,Vaira Leimane,Martie van der Walt,Laura E. Via,Grigory Volchenkov,Irma Olivos-Capcha,Hyungseok Kang	2012	163
17	Neutrophils Are the Predominant Infected Phagocytic Cells in the Airways of Patients With Active Pulmonary TB CHEST Journal ·Seok-Yong Eum,K. Nakazawa,Hubert Jacot-Guillermod,Ye Jin Lee,Jin Hee Kim,Soo-Hee Hwang,Sang-Nae Cho,Laura E. Via,Clifton E. Barry	2009	380
18	Green Fluorescent Protein: A Tool for Gene Expression and Cell Biology in Mycobacteria Humana Press eBooks ·Laura E. Via,Subramanian Dhandayuthapani,Dusanka Deretic,Vojo Deretić	2003	1
19	Green fluorescent protein as a marker for gene expression and cell biology of mycobacterial interactions with macrophages Molecular Microbiology ·Subramanian Dhandayuthapani,Laura E. Via,Christian A. Thomas,Peleg Horowitz,Dusanka Deretic,Vojo Deretić	1995	161
20	Mycobacterium tuberculosis is a natural mutant with an inactivated oxidative‐stress regulatory gene:implications for sensitivity to isoniazid Molecular Microbiology ·Vojo Deretić,W. Philipp,Subramanian Dhandayuthapani,Michal Mudd,Directorat du bassin du Danube,T. R. Garbe,Béate Heym,Laura E. Via,Stewart T. Cole	1995	149

About Laura E. Via

Laura E. Via is a scholar working on Infectious Diseases, Molecular Medicine, Epidemiology, Immunology and Surgery, having authored 101 papers that have together received 8.3k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (79 papers), Mycobacterium research and diagnosis (43 papers), Infectious Diseases and Tuberculosis (18 papers), Pneumocystis jirovecii pneumonia detection and treatment (11 papers), Cancer therapeutics and mechanisms (10 papers), Antibiotic Resistance in Bacteria (10 papers), Diagnosis and treatment of tuberculosis (9 papers) and Pneumonia and Respiratory Infections (8 papers). The work is most often cited by research in Infectious Diseases (4.9k citations), Molecular Medicine (606 citations), Epidemiology (3.7k citations), Immunology (1.4k citations) and Endocrinology (207 citations). Laura E. Via has collaborated with scholars based in United States, South Africa and South Korea. Frequent co-authors include Clifton E. Barry, C. Neal Stewart, Vojo Deretić, Véronique Dartois, Dominique J. Wiener, Dusanka Deretic, JoAnne L. Flynn, Sang-Nae Cho, N S Hibler and Lukas A. Huber. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Clinical Microbiology, PLoS ONE, BMC Infectious Diseases and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact